Compare
Johnson & Johnson vs Organon & (JNJ vs OGN)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Organon & (OGN) +117.4%; so far this year the figures are +33.5% and +93.4%.
Johnson & Johnson is the larger company by market value, about 182.7 times the size of Organon &.
On trailing earnings, JNJ trades at 41.9 times and OGN at 18.0 times.
Revenue grew +7.8% at JNJ and -3.2% at OGN over the last year.
JNJ yields 1.91%. OGN yields 0.58%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | OGN | |
|---|---|---|
| Price | $276.22 | $13.87 |
| 1-day | +1.43% | +0.58% |
| YTD | +33.47% | +93.44% |
| 1 year | +48.51% | +117.40% |
| 3 years | +85.77% | -5.32% |
| Market cap | $665.0B | $3.6B |
| P/E | 41.9 | 18.0 |
| P/S | 6.69 | 0.60 |
| P/B | 8.16 | 3.05 |
| Revenue growth | +7.80% | -3.20% |
| EPS growth | -36.40% | -59.70% |
| Gross margin % | 67.6 | 53.1 |
| Net margin % | 16.2 | 3.5 |
| ROE % | 19.7 | 17.9 |
| Debt / equity | 0.55 | 7.17 |
| FCF yield % | 3.1 | 18.5 |
| Dividend yield % | 1.91 | 0.58 |
| Beta | -0.09 | 0.68 |
| RSI (14) | 59.4 | 64.0 |
| Technical rating |